Massachusetts Mutual Life Insurance has signed a multi-year agreement with Human Longevity around its genome sequencing product, HLIQ Whole Genome.

The deal subsidizes the cost of using the platform for customers, employees and financial professionals who voluntarily enroll in the program, which allows physicians to look at an individual's genome and identify potential health risks. Though MassMutual will not receive any personal health data from Human Longevity (HLI), the company's growing database of genome information could help life insurers better understand risk and adjust product design accordingly.

Register or login for access to this item and much more

All Digital Insurance content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access